Latest news
Glenmark announced that an open-label trial of favipiravir had found the drug could treat mild COVID-19. But the full trial report points to the opposite conclusion.
Using increased ventilation or running an appropriately sized air cleaner or filter can reduce the transmission of airborne infectious diseases.
Important updates through the day about the spread of SARS-CoV-2, the new coronavirus, around the world, its consequences for living, healthcare and productivity, and the global response.
Many ants, especially those that live in small colonies, communicate without trail pheromones. Instead, they use tandem-running.
While concerns about littering on the Everest have been raised before, the new study is among the first to assess the extent of microplastic pollution.
In the 12 years since FRA has became operational, the Ministry of Tribal Affairs has no list of habitations where FRA has to be implemented.
It is essential to add genomic data from all global populations – including Africa. This will ensure that everyone can benefit from advances in health.
According to the Public Liability Insurance Act 1991, a relief fund is to be created by the owners of factories where workers handle hazardous substances.
A stroke of good fortune from a dosing error will pave the way for AstraZeneca and Oxford University to submit their COVID-19 vaccine for regulatory clearance.
A drop in international students, who spend most of their money on the higher education sector, doesn’t hurt just colleges’ bottom lines – it harms local economies as well.
An illusion of epistemic superiority has rendered Ayurvedic theories unfalsifiable, and unfalsifiable theories in turn cripple experiments.
Because Pfizer-BioNTech and Moderna vaccines have been developed in record time, many wonder whether companies cut corners or compromised safety.
